Le Lézard
Classified in: Health
Subject: FDA

Abbott Announces FDA Approval of the Alinitytm s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply


ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinitytm s System.  This new solution will bring the latest screening technology to U.S. blood and plasma centers. Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive systems. In a testing specialty that can require extensive hands-on time, the additional automation and flexibility of Alinity s will help blood and plasma centers improve productivity and maintain the highest levels of accuracy.

"Alinity s is a significant leap forward when it comes to speed, automation and efficiency for blood and plasma screening," said Louis Morrone, vice president, Transfusion Medicine, Abbott. "These elements are important to blood and plasma services of all sizes, supporting Abbott's overall mission to help people live longer, healthier lives by keeping the global blood and plasma supply safe."

Alinity s will help transform the blood and plasma screening process in terms of speed, capacity and "walk-away" time (i.e., when lab professionals are free to manage other responsibilities while the instrument processes samples) as a result of a number of new features:

"In order to ensure a safe blood and plasma supply, we need access to the most advanced technologies to screen donations," said Rachel-Louise Beddard, M.D., senior vice president and chief medical officer, QualTex Laboratories. "Alinity s will help us transform the way we conduct screening, so we can do our jobs most efficiently, allowing us to get the life-saving blood and plasma products to people facing their most critical situations."

About Alinity
Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostic platforms and simplifying diagnostic testing. Alinity systems are designed to be more efficient ? running more tests in less space, generating test results faster and minimizing human errors ? while continuing to provide quality results. The availability of the Alinity systems and tests varies by geography. More information is available at abbott.com/alinity.

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.

 

SOURCE Abbott


These press releases may also interest you

at 00:30
Mydecine Innovations Group Inc. ("Mydecine" or the "Company"), announced today that seven-time Nobel Prize-nominated scientist Dr. Malireddy Srinivasulu Reddy will be joining the Mydecine team as a Scientific Advisor. Dr. Reddy is one of the...

6 jui 2020
Since the beginning of the pandemic, Bainbridge Health has been closely monitoring network data to identify trends in the utilization of neuromuscular blockers, vasoactive agents, and sedatives. Through the analysis of smart infusion pump data and...

6 jui 2020
Physician-investigators at Johns Hopkins University Hospital report on the promising data of treatment of COVID-19 induced acute respiratory distress syndrome with allogeneic, cord blood derived T-regulatory (Treg) cell therapy (manufactured by...

6 jui 2020
Endo International plc today announced that it received U.S. Food and Drug Administration (FDA) approval of Qwotm (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO is...

6 jui 2020
A June 2 article on News Medical reports on the dangers of toothbrush sharing and whether it's safe to do so. The short answer: a definitive "no" ? even among family members. The article points out that brushing can cause small cuts along the gums...

6 jui 2020
A June 4 article on Forbes reports on how the COVID-19 pandemic may be spurring innovation in the medical and healthcare fields. The article discusses what the new normal might look like and how flexibility and open-mindedness will be a top priority...



News published on 11 july 2019 at 09:00 and distributed by: